Wilmington, DE, United States of America

Xiaodong Liu

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Xiaodong Liu in Microfluidics and Biotin Assays

Introduction

Xiaodong Liu is a prominent inventor based in Wilmington, DE (US). He has made significant contributions to the field of microfluidics and biochemistry, particularly in the development of innovative kits and devices for biotin assays. His work has implications for various applications in healthcare diagnostics.

Latest Patents

Xiaodong Liu holds a patent for "Kits, microfluidics devices, and methods for performing biotin assays." This patent describes kits that contain a chemiluminescent detection system and microfluidics devices designed to determine the concentration of biotin in a sample. The technology utilizes a sensitizer capable of generating singlet oxygen in its excited state, which is directly or indirectly bound to avidin or an analog thereof. Additionally, it features a singlet oxygen-activatable chemiluminescent compound that has biotin or an analog thereof bound to it.

Career Highlights

Xiaodong Liu is currently employed at Siemens Healthcare Diagnostics GmbH, where he continues to innovate and develop new technologies in the field of diagnostics. His expertise in microfluidics and biochemistry has positioned him as a valuable asset in the healthcare industry.

Collaborations

Xiaodong Liu has collaborated with notable colleagues, including Tie Q Wei and Zhu Teng. These partnerships have fostered a collaborative environment that enhances the development of cutting-edge technologies.

Conclusion

Xiaodong Liu's contributions to the field of microfluidics and biotin assays exemplify the impact of innovative thinking in healthcare diagnostics. His work continues to pave the way for advancements in the detection and analysis of biotin, showcasing the importance of research and development in this critical area.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…